These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 7465532

  • 21. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK, Baker LH, Fraile RJ, Izbicki RM, Vaitkevicius VK.
    Cancer Treat Rep; 1977 Mar; 61(1):59-64. PubMed ID: 67895
    [Abstract] [Full Text] [Related]

  • 23. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ, Thomas DR, Holoye PY, Boyle LE, Smith TL, Samuels ML.
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [Abstract] [Full Text] [Related]

  • 24. [A study of two protocols of multiple chemotherapy in small round cell tumours of the lung (author's transl)].
    Israël L, Breau JL, Depierre A, Choffel C, Lemarié E, Battesti JP.
    Rev Fr Mal Respir; 1981 Jan; 9(2):123-31. PubMed ID: 6166970
    [No Abstract] [Full Text] [Related]

  • 25. Recent therapeutic developments in lung cancer.
    Hansen HH, Selawry OS.
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract] [Full Text] [Related]

  • 26. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI, Bychkov MB.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract] [Full Text] [Related]

  • 27. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
    Maurer LH, Tulloh M, Eagan RT, Forcier RJ, House R.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
    [No Abstract] [Full Text] [Related]

  • 28. [Cytostatic therapy of tumors of the lung].
    De Marco F, Saviano G, Tenore G.
    Arch Monaldi; 1974 Mar; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract] [Full Text] [Related]

  • 29. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
    Mountain CF.
    Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
    [No Abstract] [Full Text] [Related]

  • 30. [Status of chemotherapy in inoperable non-small cell bronchial carcinoma].
    Brunner KW, Joss R, Goldhirsch A.
    Schweiz Rundsch Med Prax; 1983 Aug 09; 72(32):1057-62. PubMed ID: 6622423
    [No Abstract] [Full Text] [Related]

  • 31. Combined treatment of bronchogenic carcinoma with radiotherapy and cytotoxic drugs--a pilot study using prednimustine and chloroethylcyclohexylnitrosurea (CCNU).
    Bringel C, Jakobsson PA, Könyves I, Nordenskjöld B, Strander H, Wiman LG.
    Scand J Respir Dis Suppl; 1978 Aug 09; 102():223-5. PubMed ID: 278211
    [No Abstract] [Full Text] [Related]

  • 32. [Chemotherapy of small cell carcinomas of the lung].
    Flicker M, Neumann M.
    Wien Med Wochenschr; 1983 Aug 31; 133(15-16):397-402. PubMed ID: 6314680
    [Abstract] [Full Text] [Related]

  • 33. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
    Trovò MG, Tirelli U, De Paoli A, Franchin G, Roncadin M, Magri M, Galligioni E, Veronesi A, Tumolo S, Carbone A, Grigoletto E.
    Int J Radiat Oncol Biol Phys; 1982 Jun 31; 8(6):1051-4. PubMed ID: 7107434
    [Abstract] [Full Text] [Related]

  • 34. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL, Ordóñez Gallego A, Díaz Pérez MA, García de Paredes ML, Zamora P, Montero García JM.
    Med Clin (Barc); 1984 May 19; 82(19):836-9. PubMed ID: 6330470
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
    Pannuti F, Lelli G, Casadio M, Piana E, Di Marco AR.
    Cancer Treat Rep; 1980 May 19; 64(10-11):1131-4. PubMed ID: 7459899
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Chemotherapy in advanced cancer of the lung].
    Fleischer I, Wainstein R, Jovtis SL, Gibson AM, Barousse AP.
    Medicina (B Aires); 1979 May 19; 39(4):472-6. PubMed ID: 545078
    [No Abstract] [Full Text] [Related]

  • 40. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R, Sotto JJ, Wiget U, Perdrix A, Bensa JC, Ribaud P.
    Eur J Cancer (1965); 1977 May 19; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.